The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies

Cancer remains an elusive, highly complex disease and a global burden. Constant change by acquired mutations and metabolic reprogramming contribute to the high inter- and intratumor heterogeneity of malignant cells, their selective growth advantage, and their resistance to anticancer therapies. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaganjac, Morana, Milkovic, Lidija, Sunjic, Suzana Borovic, Zarkovic, Neven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699519/
https://www.ncbi.nlm.nih.gov/pubmed/33228209
http://dx.doi.org/10.3390/antiox9111151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699519/
https://www.ncbi.nlm.nih.gov/pubmed/33228209
http://dx.doi.org/10.3390/antiox9111151

Ejemplares similares